HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Liposomes (Liposome)

Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.

Also Known As:

Liposome; Liposomes, Ultra-deformable; Liposome, Ultra-deformable; Liposome, Ultradeformable; Liposomes, Ultra deformable; Liposomes, Ultradeformable; Niosome; Transferosome; Ultra-deformable Liposome; Ultra-deformable Liposomes; Ultradeformable Liposome; Niosomes; Transferosomes; Ultradeformable Liposomes

Networked: 5648 relevant articles (643 outcomes, 827 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Storm, Gert: 29 articles (11/2012 - 02/2002)
2.	Torchilin, Vladimir P: 27 articles (06/2012 - 02/2003)
3.	Ueoka, Ryuichi: 26 articles (11/2012 - 04/2002)
4.	Lee, Robert J: 21 articles (08/2012 - 05/2002)
5.	Oku, Naoto: 20 articles (12/2012 - 04/2002)
6.	Matsumoto, Yoko: 20 articles (11/2012 - 04/2002)
7.	van Rooijen, Nico: 17 articles (06/2011 - 01/2002)
8.	Maitani, Yoshie: 15 articles (12/2012 - 06/2002)
9.	Yoshida, Jun: 15 articles (05/2012 - 09/2002)
10.	Zhang, Qiang: 14 articles (12/2012 - 10/2005)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2012 - "Liposomes have been widely investigated as one of the most widely used nanocarriers in cancer therapy and have shown their potential in spatial and temporal release of bioactive agents for the effective treatment of various life-threatening diseases, including cancer. " 03/01/2003 - "FR-targeted liposomes are a highly efficacious vehicle for in vivo delivery of anticancer agents and have potential application in the treatment of FR(+) solid tumors." 03/01/1999 - "Liposome-based chemoimmunotherapy is a synergistic and highly efficacious approach to eradicate metastatic and regionally spread tumors." 07/09/2008 - "These results indicated that the vascular permeability within the tumor substantially affects the tumor accumulation of PEG liposome and may be one of the important determinants in the in vivo anti-tumor efficacy of PEG liposomal DOX." 11/20/2004 - "Fluorescence imaging studies after intravenous (i.v.) administration showed that incorporation of anisamide into liposomes significantly improved their accumulation into the tumor. " Order ALL the reference details at left...
2.	Infection 10/01/2009 - "The intramuscular immunization of mice with the peptide-liposome conjugates along with CpG resulted in the efficient induction of antiviral CD8(+) T-cell responses which conferred complete protection against not only LCMV Armstrong but also a highly virulent mutant strain, clone 13, that establishes persistent infections in immunocompetent mice. " 06/01/1998 - "Since the efficacy of gene therapy is dependent on the number of cells modified, which is in turn dependent upon the balance between transduction and biological clearance of the vector, the ability of cationic liposomes to form stable complexes with retroviral vectors and enhance their rate of infection is likely to be important for in vivo application." 08/01/2000 - "In comparison to the control mice immunized with phosphate-buffered saline and empty liposomes, immunization with free LAg led to significant levels of protection against infection with virulent promastigotes. " 06/01/1989 - "Moreover, the ability to increase the doses of CQ per injection after liposome encapsulation allowed successful treatment of infections with CQ-resistant Plasmodium berghei which could not be cured by a 7-day course with the maximum tolerable dose of free CQ of 0.8 mg/mouse/day." 04/01/2009 - "Our results indicate that photosensitizer entrapped in micelle exert similar or better PDI efficacy than that of liposome, which indicates this formulation may be useful for the treatment of local infections in the future." Order ALL the reference details at left...
3.	Neoplasm Metastasis (Metastasis) 01/01/1983 - "When mice bearing metastases are treated with macrophage-activating agents contained within liposomes, metastasis-associated macrophages are activated to the tumoricidal state and the metastatic lesions are simultaneously eradicated. " 10/14/2011 - "The in vivo fluorescence imaging and pharmacodynamic studies showed that LyP-1 modification increased liposome uptake by metastatic LNs and that L-LS/DOX significantly decreased metastatic LN growth and LN metastasis rate. " 01/01/1996 - "Potentials of liposomes in diagnosis and treatment of pulmonary metastases: an experimental study in the rat." 07/01/1984 - "The synergism between MAF and MDP encapsulated in liposomes was also observed in therapeutic studies of mice bearing well established, spontaneous lung and lymph node metastases. " 12/01/2012 - "The results indicate a possible use of liposome encapsulated ATRA in prevention of lung metastasis." Order ALL the reference details at left...
4.	Carcinoma (Carcinomatosis) 10/09/2008 - "The efficacy of these liposomes was studied in DU145 human prostate carcinoma cells. " 01/01/2012 - "In vitro cytotoxicity studies carried out on ER-positive MCF-7 breast carcinoma cells revealed that ES-pH-sensitive-SL formulation was more cytotoxic than non-pH-sensitive targeted liposomes (ES-SL). " 09/15/2005 - "The experiments in the current study provide a biologic rationale for treatment of patients suffering from pancreatic carcinoma with this nontoxic phytochemical encapsulated in liposomes for systemic delivery." 08/01/2005 - "The aggregation behaviour of human platelets and HT29 colon carcinoma cells in the presence of liposomes with a modified surface has been investigated in the present study. " 01/01/2012 - "Targeted liposomes showed efficient and specific receptor-mediated binding to ovarian carcinoma cells in vitro, but the difference in cytotoxicity between targeted and non-targeted liposomes remained small. " Order ALL the reference details at left...
5.	Breast Neoplasms (Breast Cancer) 11/01/2012 - "The TQ-LP liposomes were effective in suppressing the proliferation of breast cancer cell lines MCF-7 and T47D, and at the same time exerting very low toxicity on normal periodontal ligament fibroblast. " 02/06/1997 - "To test the therapeutic efficacy of E1A, we used both adenovirus-mediated and cationic liposome-mediated E1A gene delivery systems in an orthotopic breast cancer animal model. " 01/01/2012 - "In this review, we discuss the recent advancements made in the development of liposome-based chemotherapeutics with respect to improved drug transfer for use in breast cancer therapy." 01/01/2008 - "To improvethe targeting efficacy for breast cancer treatment, an 8.3-kDa HER2-specific Affibody molecule (Z(HER2:342)-Cys) was conjugated to the surface of liposomes. " 12/10/2000 - "We also examined the efficacy of HSP-tk gene therapy in vivo by implanting breast cancer in subcutaneous and intraperitoneal models of BALB/c nude mice targeted by the HVJ-anionic liposome method. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Doxorubicin (Adriamycin)
2.	Liposomes (Liposome)
3.	Antigens
4.	DNA (Deoxyribonucleic Acid)
5.	Amphotericin B (Amphotericin)
6.	Ciprofloxacin (Cipro)
7.	Cholesterol
8.	Transferrin (beta 2 Transferrin)
9.	Clodronic Acid (Clodronate)
10.	Hemoglobins (Hemoglobin)

Related Therapies and Procedures

1.	Heterologous Transplantation (Xenotransplantation)
2.	Drug Therapy (Chemotherapy)
3.	Immunotherapy
4.	Induced Hyperthermia (Thermotherapy)
5.	Injections

blog comments powered by Disqus

TREATMENT OPTIONS
for Neoplasms,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 25767 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$24.95 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$490.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>